key topics
navigation
|
Osteoporosis
Osteoporosis is a skeletal disease in which there is an abnormal loss of bone density. Causes of the condition range from the age-related bone loss and the loss of estrogen in menopausal women to metabolic diseases and nutritional deficiencies. According to the National Osteoporosis Foundation, women are four times more likely to develop osteoporosis than men.
Conquering Osteoporosis
Given the prevalence of osteoporosis, these authors offer a primer on noted risk factors and pertinent insights on treatment options ranging from exercise and nutrition to pharmacologic interventions.
How To Prevent And Manage Osteoporosis
Given the emerging statistics on the prevalence of osteoporosis, this author takes a closer look at key diagnostic techniques and reviews an array of treatment modalities.
Bisphosphonates For Osteoporosis: A Closer Look At Efficacy And Safety
Given the prevalence of osteoporosis and the rise of bisphosphonate medications, this author offers a thorough review of the literature and key insights from her clinical experience in treating this condition.
Pregabalin Gains FDA Approval For Fibromyalgia
The 100-patient study, which was recently published in the Journal of Rheumatology, found that 39 percent of patients studied achieved an ACR 20 response at 12 weeks after having subcutaneous injections of adalimumab 40 mg every other week. Revealing RA’s Impact On Sleep: What One Study ShowsBy Aaron Becker, Associate Editor A recent study published in Musculoskeletal Care determined that 35 percent of the rheumatoid arthritis (RA) patients enrolled experienced sleep disruption that ...
What You Should Know About Arthritis & Comorbidities
In an intriguing case study review, this author emphasizes the importance of assessing comorbid conditions when evaluating patients with painful conditions.
Can Bone Scans Facilitate Early Detection Of Knee Arthritis?
Scott Dye, MD, says technetium bone scans can enable practitioners to detect a loss of osseous homeostasis in the knees of athletes who have had sports-related injuries that may increase their risk of developing arthritis in the knee. By recognizing this loss of osseous homeostasis years before the development of radiographically identifiable degenerative arthritis, Dr. Dye says clinicians can encourage patients to pursue simple modifications of activities that may help restore osseous ...
Secrets To Coding For RA And Osteoporosis Drugs
Secrets To Coding For RA And Osteoporosis Drugs Coding Corner: Secrets To Coding For RA And Osteoporosis Drugs - By Antanya A. Chung, CPC and Melesia R. Collins, CPC Rheumatoid arthritis (RA) usually requires a lifelong treatment regimen that may include medications, physical therapy, exercise, education and possibly surgery. Clinicians may prescribe disease-modifying antirheumatic drugs (DMARDs) after less potent drugs prove to be ineffective for a patient. Other DMARDs Clinicians May ...
Study Offers Promise In Predicting RA Risk In Patients With UA
One of the more confounding dilemmas that clinicians face is when patients present with undifferentiated arthritis (UA). While these patients reportedly comprise the majority of those who come into rheumatology practices with recently developed arthritis, UA defies a more defined classification criteria and the lack of a more specific diagnosis leads to less clarity when it comes to treating the disease. Clinicians are subsequently torn between initiating treatment with methotrexate, in order to address symptoms and help inhibit progression of the disease, or foregoing treatment as reportedly upward of 50 percent of patients with UA have spontaneous remission.
New Innovations In Pain Management
Given the aging of the population and the increasing prevalence of chronic pain, this author interviews leading researchers and clinicians about new modalities and reemerging medications that may have a significant impact for patients.
Febuxostat: A New Alternative For Hyperuricemia?
|
A complimentary CME Webcast Event
To register for this Web Archive program, click on Complimentary CME Webcast Event
This activity is for nurse practitioners, physician assistants, rheumatologists and internal medicine
physicians who treat patients with rheumatoid arthritis (RA).
Panelists/Lectures
"What You Should Know About Treating Early RA"
Nathan Wei, MD
Clinical Director
Arthritis and
Osteoporosis Center
Frederick, Md.
"A Closer Look At The Efficacy And Safety Of Combination Therapy With Anti-TNF Agents"
Philip Mease, MD
Clinical Professor
University of Washington
School of Medicine
Chief, Rheumatology Clinical Research
Swedish Hospital Medical Center
Seattle
"What The Studies Reveal About Emerging Therapies For RA"
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas,Tx.
This activity is supported by an educational grant from Genentech and Biogen Idec. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A complimentary CME Webcast Event
ON DEMAND
(Q&A with panelists to follow lectures)
To register for this Webcast program, click on Complimentary CME Webcast
This activity is geared to physicians, rheumatologists, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.
Agenda And Faculty
“Treating RA: The Shift To A More Aggressive Therapeutic Approach”
Linda Davis, MHS, PA-C
Assistant Professor
University Of North Texas Health Science Center
“What The Literature Reveals About Combination Therapy”
Kevin M. Latinis, MD, PhD
Division of Allergy, Clinical Immunology and Rheumatology
University of Kansas Medical Center
“New Biologic DMARDs: Can They Have An Impact?”
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas, Texas
This activity is supported by an educational grant from Bristol-Myers Squibb. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A complimentary CME Web Archive Event
To register for this Web Archive program, click on Complimentary CME Web Archive Event
This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat osteoarthritis.
Agenda And Faculty
“A Closer Look At The Role Of Intraarticular Injections”
Frank Caruso, PA-C
Physician Assistant
Wake Forest University Baptist Medical Center
Winston-Salem, NC
“What The Literature Reveals About Viscosupplementation”
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, MD
“Mastering The Technique Of Intraarticular Injections”
Mike Rudzinski, PA-C
Physician Assistant
Buffalo Veterans Affairs Medical Center
Buffalo, NY
This activity is supported by an educational grant from Genzyme. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A Complimentary CME Webcast Event
A Complimentary, On-Demand CME Webcast
To register for this Webcast program, click on Complimentary CME Webcast Event
This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.
AGENDA and FACULTY
"Reviewing The Role of DMARDs In Treating RA"
Don Flinn, PA-C
Physician Assistant, McBride Clinic, Oklahoma City, Ok.
Vice-President, Society Of Physician Assistants In Rheumatology
"Assessing The Potential of Biologic Therapies"
Mark Genovese, MD
Associate Professor of Medicine
Division of Immunology And Rheumatology
Stanford University School Of Medicine
"What You Should Know About Infusion Therapy"
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, Md.
This activity is supported by an educational grant from Bristol-Myers Squibb.
The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
|